Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa.

Asundexian is a potent oral FXIa inhibitor with antithrombotic efficacy in arterial and venous thrombosis models in prevention and intervention settings, without increasing bleeding.